Skip to main content
Fig. 2 | BMC Psychiatry

Fig. 2

From: Abnormally low prolactin levels in schizophrenia patients after switching to aripiprazole in a randomized trial: a biomarker for rebound in psychotic symptoms?

Fig. 2

The cumulative proportion of patients with rebound in PANSS positive symptoms (▲) at follow-up measured time points, which are the 14th Day, 28th Day, and 56th Day, and of patients with abnormally low prolactin levels () at follow-up measured time points, which are the 14th Day and 56th Day. Concurrency of the two trends over time in the cumulative proportions is shown in a whole samples, N = 63, b male patients, N = 26, and c female patients, N = 37. The β coefficient presents the slope of the cumulated line. P value is from testing whether the β coefficient of positive rebound is different from that of low prolactin levels

Back to article page